Lupin Limited has informed the Exchange regarding a press release dated January 23, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP.".
Lupin Limited has informed the Exchange regarding a press release dated January 23, 2024, titled "Lupin Receives Tentative Approval from U.S. FDA for Rivaroxaban Tablets USP.".